Dr. Bernard Thébaud is a senior scientist with the Ottawa Hospital Research Institute (OHRI) and a neonatologist with the Children’s Hospital of Eastern Ontario (CHEO), where he provides care to critically ill newborns. He is also a Professor of Pediatrics at the University of Ottawa.
Dr. Thébaud obtained his MD at the University Louis Pasteur in Strasbourg, France in 1991 and trained in Pediatrics and Neonatology at the University Paris V, where he also obtained his MSc and PhD, before completing a 2-year postdoctoral fellowship at the University of Alberta.
Dr. Thébaud joined OHRI and CHEO in 2012 to accelerate the clinical translation of cell-based therapies for complications of prematurity, the main cause of death in children below the age of 5 years. His research group is focused on the therapeutic potential of mesenchymal stromal cells and endothelial colony forming cells in experimental models of prematurity to pave the way for these cell products to benefit patients. Over the next five years, his goal is to bring safe and effective cell-based therapies for lung diseases into the clinic.
Dr. Thébaud holds the University of Ottawa Partnership Research Chair in Regenerative Medicine. His research is funded by a CIHR Foundation Scheme grant, the Heart and Stroke Foundation of Canada, the Stem Cell Network, the Ontario Institute of Regenerative Medicine and the Ontario Thoracic Society.
Friday, February 14
9:00 AM – 9:30 AM